Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine.
Ferraccioli GF
•
Salaffi F
•
Casatta L
altro
BELTRAMI, Carlo Alberto
1996
Periodico
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
WOS
Archivio
Diritti
metadata only access